Pneumonia Therapeutics Market by Therapeutics (Prevention Vaccines and Treatment Drugs) and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the pneumonia therapeutics market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the pneumonia therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pneumonia therapeutics market on a global level.

This report offers a comprehensive view of the global pneumonia therapeutics market along with market trends, drivers, and restraints. This report includes a detailed competitive scenario and portfolio of the key vendors. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The study provides a decisive view of the pneumonia therapeutics market by segmenting it based on therapeutics, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. By therapeutics, the market includes prevention vaccines and treatment drugs. The distribution channel segment includes hospital pharmacy, retail pharmacy, and online pharmacy. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into the U.S., Canada, Germany, UK, France, China, Italy, Japan, India, and Brazil.

Some key participants operating in the global pneumonia therapeutics market include GlaxoSmithKline, Sanofi, Merck & Co. Inc., Novartis AG, Eli Lilly and Company, AstraZeneca, Merck & Co., Pfizer, Baxter International Inc., Allergan, and Lupin Pharmaceuticals Inc., among others.

This report segments the global pneumonia therapeutics market into:

Global Pneumonia Therapeutics Market: Therapeutics Analysis

	Prevention Vaccines
	Treatment Drugs

Global Pneumonia Therapeutics Market: Distribution Channel Analysis

	Hospital pharmacy
	Retail pharmacy
	Online pharmacy

Global Pneumonia Therapeutics Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa